BIOXYTRAN, INC Balance Sheet
BIXT|7 years of annual SEC 10-K data (FY2011-FY2017)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$110
FY2017
Cash
N/A
Cash and equivalents
Total Debt
N/A
FY2017
Shareholder Equity
-$1,309
FY2017
BIOXYTRAN, INC had $110 in total assets with negative shareholders' equity of $1,309 as of FY2017.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -7713.38 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $11.1K | $3.5K | $6.2K | $20.7K | $5.5K | $16.5K |
| Accounts Receivable | $23.0K | $9.6K | - | - | $58.3K | $27.4K | - |
| Inventory | $5.3K | $6.3K | - | - | $14.1K | $11.8K | $25.4K |
| Current Assets | $110 | $27.0K | $3.5K | $6.2K | $93.1K | $299.4K | $48.4K |
| PP&E (Net) | $682.2K | $24.7K | $52.3K | $107.1K | $165.3K | $129.1K | $167.6K |
| Total Assets | $110 | $51.7K | $55.8K | $113.3K | $258.4K | $428.4K | $216.1K |
| Current Liabilities | $1.4K | $342.3K | $251.0K | $334.7K | $183.0K | $74.4K | $52.8K |
| Shareholders' Equity | -$1.3K | -$290.6K | -$195.2K | -$221.5K | $75.4K | $354.1K | $163.3K |